AN2 Therapeutics
boron based chemistry novel oncology targets | AN2 Therapeutics
Company
Deck Type
Sector
Industry
Deck date
February 2025
Slide
31 of 36
Similar slides by AN2 Therapeutics
See diffirences between slides (animation)
Investor Presentation
March 2025
boron based chemistry novel oncology targets | AN2 Therapeutics
Related slides by other companies
Exscientia
Results
August 2023
and potential for a better clinical development strategy model driven adaptive learning in the clinic to insight | Exscientia
AbCellera
Investor Conference
April 2023
drug development has three steps | AbCellera
AbCellera
Results
November 2022
i a a into preclinical and clinical development first target | AbCellera
Recursion Pharmaceuticals
Investor Day
January 2023
clinical target alpha and gamma reaching enabling studies in continuing to augment our digital chemistry and predictive capabilities property assessment continuing to drive potential first in disease or first in class programs at greater and scale looking ahead beyond | Recursion Pharmaceuticals
Other recent decks by AN2 Therapeutics
See all presentations (4 decks)
Investor Presentation
March 2025
Investor Presentation
August 2022
IPO
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io